Aptinyx NYX-458-2006: A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment Associated With Parkinson's Disease

April 23, 2021
https://clinicaltrials.gov/ct2/show/NCT04148391
Parkinson Disease
Principal Investigator: Peter A Le Witt, MD
Parkinson Disease
Accepting Participants
248-661-7257